Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Retailers - NEC
- Sub-Industry: Health Care Distributors
- Symbol: NYSE:CAH
- CUSIP: 14149Y10
- Web: www.cardinalhealth.com
Capitalization:- Market Cap: $24.1 billion
- Outstanding Shares: 315,882,000
Average Prices:- 50 Day Moving Avg: $76.85
- 200 Day Moving Avg: $77.11
- 52 Week Range: $62.70 - $85.52
P/E:- Trailing P/E Ratio: 18.21
- Foreward P/E Ratio: 14.48
- P/E Growth: 2.89
Sales & Book Value:- Annual Revenue: $128.39 billion
- Price / Sales: 0.19
- Book Value: $21.03 per share
- Price / Book: 3.63
Dividend:- Annual Dividend: $1.85
- Dividend Yield: 2.4%
Profitability:- EBIDTA: $3.1 billion
- Net Margins: 1.05%
- Return on Equity: 25.78%
- Return on Assets: 4.89%
Debt:- Debt-to-Equity Ratio: 0.73%
- Current Ratio: 1.13%
- Quick Ratio: 0.54%
Misc:- Average Volume: 2.04 million shs.
- Beta: 0.81
- Short Ratio: 4.82
Frequently Asked Questions for Cardinal Health (NYSE:CAH)
What is Cardinal Health's stock symbol?
Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."
How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?
Cardinal Health announced a quarterly dividend on Wednesday, May 3rd. Investors of record on Monday, July 3rd will be given a dividend of $0.4624 per share on Saturday, July 15th. This represents a $1.85 annualized dividend and a yield of 2.42%. The ex-dividend date is Thursday, June 29th. This is a positive change from Cardinal Health's previous quarterly dividend of $0.45. View Cardinal Health's Dividend History.
How were Cardinal Health's earnings last quarter?
Cardinal Health, Inc. (NYSE:CAH) posted its quarterly earnings data on Monday, May, 1st. The company reported $1.53 EPS for the quarter, topping analysts' consensus estimates of $1.46 by $0.07. The business had revenue of $31.82 billion for the quarter, compared to the consensus estimate of $32.30 billion. Cardinal Health had a return on equity of 25.78% and a net margin of 1.05%. The firm's revenue was up 3.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.43 EPS. View Cardinal Health's Earnings History.
When will Cardinal Health make its next earnings announcement?
Where is Cardinal Health's stock going? Where will Cardinal Health's stock price be in 2017?
17 brokers have issued 1-year target prices for Cardinal Health's stock. Their predictions range from $72.00 to $93.00. On average, they anticipate Cardinal Health's stock price to reach $83.46 in the next twelve months. View Analyst Ratings for Cardinal Health.
What are analysts saying about Cardinal Health stock?
Here are some recent quotes from research analysts about Cardinal Health stock:
- 1. According to Zacks Investment Research, "Cardinal Health ended third-quarter fiscal 2017 on a solid note, courtesy of encouraging performance in the Medical segment. However, revenues missed the estimate mark in the quarter. Profits at the Pharmaceutical segment were hurt by generic pharmaceutical pricing and the loss of a major Pharmaceutical Distribution customer. Over the past one year, the company has underperformed the broader industry with respect to price. Increasing generic pricing pressure is a major headwind at the moment. Moreover, intensifying competition and customer concentration are other bottlenecks. Sluggish macroeconomic situations and a tough product pricing environment are also likely to dent growth. The company is banking on strategic buyouts, joint ventures and supply agreements to drive growth. Despite the strong prospects, integration risks are likely to mar the company's bottom line in the near term." (7/4/2017)
- 2. Leerink Swann analysts commented, "We were disappointed by the pharmaceutical operating margin of 1.92% (-24 bps y/y) which was below our 2.02%E, though operating income itself was ahead of our estimate. The Medical division revenue was slightly ahead of our model, and operating income of $122M (margin of 3.80% vs. 4.49%E) was roughly in-line. Cordis is seasonal in nature and as a result earnings were good in Medical last quarter. F2017 Outlook Tough but Long-term +10-15% EPS Growth Guidance Good. Management provided F2017 guidance of $5.48-$5.73. The midpoint of guidance of $5.61 is below consensus of $5.69 and CAH indicated that F1Q:17 pharma operating income would decline in the ‘high teens to low twenty percent range,’ though be flat for F2017 relative to F2016. While this would normally be highly worrisome, management did a good job explaining that F1Q:16 EPS grew +38% y/y and the comp. is difficult due largely to generic pricing trends. In CAH’s prepared presentation, and on the call, management highlighted that they ‘aspire’ to grow adjusted EPS by +10-15% y/y over the longer term. Net customer activity and pricing is expected to have a ($0.55) headwind on F2017 results, tied mainly to Safeway, generic deflation, and less incremental earnings from new generic launches and Red Oak." (8/3/2016)
Are investors shorting Cardinal Health?
Cardinal Health saw a increase in short interest in June. As of June 30th, there was short interest totalling 10,498,346 shares, an increase of 55.4% from the June 15th total of 6,756,952 shares. Based on an average trading volume of 2,700,926 shares, the days-to-cover ratio is currently 3.9 days. Currently, 3.3% of the company's shares are sold short.
Who are some of Cardinal Health's key competitors?
Some companies that are related to Cardinal Health include Becton, Dickinson and Company (BDX), Takeda Pharmaceutical (TKPYY), Vertex Pharmaceuticals Incorporated (VRTX), Boston Scientific Corporation (BSX), Express Scripts Holding Company (ESRX), McKesson Corporation (MCK), Intuitive Surgical (ISRG), Baxter International (BAX), Humana (HUM), Teva Pharmaceutical Industries Limited (TEVA), HCA Holdings (HCA), Zoetis (ZTS), Alexion Pharmaceuticals (ALXN), Fresenius Medical Care Corporation (FMS), Actelion (ALIOF), Incyte Corporation (INCY), Zimmer Biomet Holdings (ZBH) and Illumina (ILMN).
Who are Cardinal Health's key executives?
Cardinal Health's management team includes the folowing people:
- George S. Barrett, Chairman of the Board, Chief Executive Officer
- Michael C. Kaufmann, Chief Financial Officer
- Donald M. Casey Jr., Chief Executive Officer - Medical Segment
- Jon L. Giacomin, Chief Executive Officer - Pharmaceutical segment
- Pamela O. Kimmet, Chief Human Resource Officer
- Patricia B. Morrison, Executive Vice President - Customer Support Services and Chief Information Officer
- Craig S. Morford, Chief Legal and Compliance Officer
- Gregory B. Kenny, Lead Independent Director
- David John Anderson, Independent Director
- Colleen F. Arnold, Independent Director
Who owns Cardinal Health stock?
Cardinal Health's stock is owned by many different of institutional and retail investors. Top institutional investors include APG Asset Management N.V. (0.46%), Hexavest Inc. (0.31%), Bank of Montreal Can (0.22%), US Bancorp DE (0.13%), CWM LLC (0.11%) and National Pension Service (0.09%). Company insiders that own Cardinal Health stock include Carole S Watkins, Craig S Morford, Donald M Jr Casey, Falk T Stephen, George S Barrett, Jon L Giacomin, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.
Who sold Cardinal Health stock? Who is selling Cardinal Health stock?
Cardinal Health's stock was sold by a variety of institutional investors in the last quarter, including US Bancorp DE, Reinhart Partners Inc., Hexavest Inc., Whittier Trust Co., Denali Advisors LLC, NN Investment Partners Holdings N.V., Aperio Group LLC and Huntington National Bank. Company insiders that have sold Cardinal Health stock in the last year include Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Patricia Morrison and Stuart G Laws. View Insider Buying and Selling for Cardinal Health.
Who bought Cardinal Health stock? Who is buying Cardinal Health stock?
Cardinal Health's stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Manning & Napier Advisors LLC, Mn Services Vermogensbeheer B.V., National Pension Service, APG Asset Management N.V., CrestPoint Capital Management LLC, Farmers & Merchants Investments Inc. and Sit Investment Associates Inc.. View Insider Buying and Selling for Cardinal Health.
How do I buy Cardinal Health stock?
Shares of Cardinal Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cardinal Health's stock price today?
One share of Cardinal Health stock can currently be purchased for approximately $76.29.
MarketBeat Community Rating for Cardinal Health (NYSE CAH)MarketBeat's community ratings are surveys of what our community members think about Cardinal Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Cardinal Health (NYSE:CAH) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 14 Hold Ratings, 3 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.18) |
| Consensus Price Target: | $83.46 (9.40% upside) |
Analysts' Ratings History for Cardinal Health (NYSE:CAH)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/13/2017 | Credit Suisse Group | Reiterated Rating | Outperform | $81.00 -> $87.00 | Low |  |
| 7/4/2017 | Evercore ISI | Reiterated Rating | Outperform | | N/A | |
| 5/17/2017 | Jefferies Group LLC | Initiated Coverage | Hold -> Hold | $77.00 | Medium | |
| 4/28/2017 | Tigress Financial | Initiated Coverage | Neutral -> Neutral | | Low | |
| 4/25/2017 | Cowen and Company | Lower Price Target | Market Perform | $89.00 -> $82.00 | Low | |
| 4/22/2017 | Barclays PLC | Reiterated Rating | Overweight | $88.00 -> $82.00 | Low | |
| 4/21/2017 | Leerink Swann | Set Price Target | Hold | $72.00 | Low | |
| 4/19/2017 | William Blair | Downgrade | Outperform -> Market Perform | | Low | |
| 4/4/2017 | Needham & Company LLC | Initiated Coverage | Hold | | Low | |
| 1/3/2017 | Mizuho | Downgrade | Buy -> Neutral | $79.00 | N/A | |
| 10/28/2016 | Robert W. Baird | Downgrade | Outperform -> Neutral | $92.00 -> $82.00 | N/A | |
| 10/10/2016 | Cleveland Research | Downgrade | Buy -> Neutral | | N/A | |
| 9/19/2016 | Bank of America Corporation | Reiterated Rating | Hold | $90.00 | N/A | |
| 9/16/2016 | Goldman Sachs Group, Inc. (The) | Downgrade | Buy -> Neutral | $90.00 -> $83.00 | N/A | |
| 9/12/2016 | Morgan Stanley | Reiterated Rating | Hold | $91.00 | N/A | |
| 8/4/2016 | Deutsche Bank AG | Boost Price Target | Hold | $83.00 -> $89.00 | N/A | |
| 8/3/2016 | Citigroup Inc. | Boost Price Target | Neutral | $87.00 -> $93.00 | N/A | |
| 6/20/2016 | FBR & Co | Reiterated Rating | Buy | | N/A | |
| 6/13/2016 | Royal Bank Of Canada | Reiterated Rating | Buy | | N/A | |
| 6/1/2016 | Raymond James Financial, Inc. | Downgrade | Outperform -> Market Perform | | N/A | |
| 4/18/2016 | Avondale Partners | Initiated Coverage | Outperform | $111.00 | N/A | |
(Data available from 7/23/2015 forward)
Earnings History for Cardinal Health (NYSE:CAH)Earnings History by Quarter for Cardinal Health (NYSE CAH)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/31/2017 | | | | | | | | |
| 5/1/2017 | Q3 2017 | $1.46 | $1.53 | $32.30 billion | $31.82 billion | View | Listen | |
| 2/7/2017 | Q217 | $1.23 | $1.34 | $33.63 billion | $33.10 billion | View | Listen | |
| 10/31/2016 | Q117 | $1.21 | $1.24 | $31.12 billion | $32.00 billion | View | Listen | |
| 8/2/2016 | Q416 | $1.13 | $1.14 | $31.06 billion | $31.40 billion | View | N/A | |
| 4/28/2016 | Q316 | $1.33 | $1.43 | $30.54 billion | $30.70 billion | View | Listen | |
| 2/1/2016 | Q216 | $1.26 | $1.30 | $29.23 billion | $31.40 billion | View | N/A | |
| 11/2/2015 | Q116 | $1.10 | $1.38 | $27.19 billion | $28.10 billion | View | N/A | |
| 7/30/2015 | Q415 | $0.99 | $1.00 | $26.05 billion | $27.50 billion | View | Listen | |
| 4/30/2015 | Q3 | $1.16 | $1.19 | $24.40 billion | $25.38 billion | View | N/A | |
| 1/29/2015 | Q215 | $1.11 | $1.20 | $23.43 billion | $25.50 billion | View | N/A | |
| 10/30/2014 | Q115 | $0.96 | $1.00 | $22.43 billion | $24.07 billion | View | N/A | |
| 8/4/2014 | Q414 | $0.81 | $0.83 | $21.88 billion | $2.90 billion | View | N/A | |
| 5/1/2014 | Q314 | $1.01 | $1.01 | $21.72 million | $21.40 million | View | N/A | |
| 1/31/2014 | Q214 | $0.84 | $0.79 | $20.74 billion | $22.20 billion | View | N/A | |
| 10/31/2013 | Q114 | $0.86 | $1.10 | $22.73 billion | $24.50 billion | View | N/A | |
| 8/1/2013 | Q4 2013 | $0.77 | $0.79 | $24.56 billion | $25.40 billion | View | N/A | |
| 5/2/2013 | Q3 2013 | $0.95 | $1.20 | $24.72 billion | $24.60 billion | View | N/A | |
| 2/5/2013 | Q2 2013 | $0.86 | $0.93 | $24.61 million | $22.75 million | View | N/A | |
| 10/30/2012 | Q113 | $0.79 | $0.81 | $26.33 million | $25.90 million | View | N/A | |
| 8/2/2012 | | $0.73 | $0.73 | | | View | N/A | |
| 5/3/2012 | | $0.88 | $0.94 | | | View | N/A | |
| 2/2/2012 | | $0.77 | $0.81 | | | View | N/A | |
| 10/27/2011 | | $0.72 | $0.73 | | | View | N/A | |
| 8/4/2011 | | $0.58 | $0.59 | | | View | N/A | |
| 4/28/2011 | | $0.69 | $0.75 | | | View | N/A | |
| 2/3/2011 | | $0.61 | $0.69 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Cardinal Health (NYSE:CAH)2017 EPS Consensus Estimate: $5.28
2018 EPS Consensus Estimate: $5.24
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | $1.21 | $1.26 | $1.23 |
| Q2 2017 | 3 | $1.20 | $1.33 | $1.26 |
| Q3 2017 | 3 | $1.43 | $1.60 | $1.50 |
| Q4 2017 | 4 | $1.24 | $1.41 | $1.29 |
| Q1 2018 | 3 | $1.16 | $1.18 | $1.17 |
| Q2 2018 | 3 | $1.22 | $1.42 | $1.33 |
| Q3 2018 | 3 | $1.41 | $1.57 | $1.47 |
| Q4 2018 | 3 | $1.25 | $1.30 | $1.28 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Cardinal Health (NYSE:CAH)| Most Recent Dividend: | 7/15/2017 |
| Annual Dividend: | $1.85 |
| Dividend Yield: | 2.42% |
| Dividend Growth: | 13.10% (3 Year Average) |
| Payout Ratio: | 44.05% (Trailing 12 Months of Earnings)
34.58% (Based on This Year's Estimates)
35.10% (Based on Next Year's Estimates)
|
| Track Record: | 12 Years of Consecutive Dividend Growth |
Dividend History by Quarter for Cardinal Health (NYSE CAH)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 5/3/2017 | quarterly | $0.46 | 2.54% | 6/29/2017 | 7/3/2017 | 7/15/2017 |
| 2/2/2017 | quarterly | $0.45 | 2.4% | 3/30/2017 | 4/3/2017 | 4/15/2017 |
| 11/3/2016 | quarterly | $0.45 | 2.76% | 12/29/2016 | 1/3/2017 | 1/15/2017 |
| 8/8/2016 | quarterly | $0.45 | 2.14% | 9/29/2016 | 10/3/2016 | 10/15/2016 |
| 5/4/2016 | quarterly | $0.45 | 2.29% | 6/29/2016 | 7/1/2016 | 7/15/2016 |
| 2/2/2016 | quarterly | $0.39 | 2% | 3/30/2016 | 4/1/2016 | 4/15/2016 |
| 11/4/2015 | quarterly | $0.39 | 1.76% | 12/30/2015 | 1/4/2016 | 1/15/2016 |
| 8/5/2015 | quarterly | $0.39 | 1.83% | 9/29/2015 | 10/1/2015 | 10/15/2015 |
| 5/6/2015 | quarterly | $0.39 | 1.82% | 6/29/2015 | 7/1/2015 | 7/15/2015 |
| 2/3/2015 | quarterly | $0.34 | 1.62% | 3/30/2015 | 4/1/2015 | 4/15/2015 |
| 11/5/2014 | quarterly | $0.34 | 1.72% | 12/30/2014 | 1/2/2015 | 1/15/2015 |
| 8/6/2014 | quarterly | $0.34 | 1.96% | 9/29/2014 | 10/1/2014 | 10/15/2014 |
| 5/7/2014 | quarterly | $0.34 | 2.14% | 6/27/2014 | 7/1/2014 | 7/15/2014 |
| 2/5/2014 | quarterly | $0.30 | 1.83% | 3/28/2014 | 4/1/2014 | 4/15/2014 |
| 11/6/2013 | quarterly | $0.30 | 1.99% | 12/30/2013 | 1/2/2014 | 1/15/2014 |
| 8/7/2013 | quarterly | $0.30 | 2.35% | 9/27/2013 | 10/1/2013 | 10/15/2013 |
| 5/2/2013 | quarterly | $0.30 | 2.61% | 6/27/2013 | 7/1/2013 | 7/15/2013 |
| 2/6/2013 | quarterly | $0.28 | 2.46% | 3/27/2013 | 4/1/2013 | 4/15/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Cardinal Health (NYSE:CAH)Insider Ownership Percentage: 0.94%
Institutional Ownership Percentage: 87.52%
Insider Trades by Quarter for Cardinal Health (NYSE:CAH)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/12/2017 | Jon L Giacomin | CEO of Cardinal Health's pharmaceutical segment | Sell | 23,270 | $72.87 | $1,695,684.90 | |
| 2/10/2017 | George S Barrett | Chairman | Sell | 217,994 | $77.23 | $16,835,676.62 | |
| 11/10/2016 | George S Barrett | Chairman | Sell | 217,995 | $71.29 | $15,540,863.55 | |
| 8/18/2016 | Patricia Morrison | Insider | Sell | 43,959 | $82.50 | $3,626,617.50 | |
| 8/18/2016 | Stuart G Laws | SVP | Sell | 9,703 | $82.45 | $800,012.35 | |
| 8/16/2016 | Jon L Giacomin | CEO | Sell | 47,251 | $82.77 | $3,910,965.27 | |
| 8/11/2016 | Craig S Morford | Insider | Sell | 12,697 | $83.13 | $1,055,501.61 | |
| 8/10/2016 | Donald M Jr. Casey | CEO | Sell | 59,180 | $83.59 | $4,946,856.20 | |
| 8/10/2016 | George S Barrett | Chairman | Sell | 250,000 | $83.63 | $20,907,500.00 | |
| 8/9/2016 | George S Barrett | CEO | Sell | 129,818 | $83.76 | $10,873,555.68 | |
| 8/8/2016 | George S Barrett | CEO | Sell | 20,428 | $83.75 | $1,710,845.00 | |
| 5/20/2016 | Carole S Watkins | Insider | Sell | 84,617 | $77.33 | $6,543,432.61 | |
| 11/6/2015 | Falk T. Stephen | EVP | Sell | 30,085 | $87.66 | $2,637,251.10 | |
| 8/20/2015 | George S. Barrett | CEO | Sell | 300,000 | $83.08 | $24,924,000.00 | |
| 5/12/2015 | Falk T Stephen | EVP | Sell | 39,428 | $86.12 | $3,395,539.36 | |
| 5/11/2015 | George S Barrett | CEO | Sell | 300,000 | $86.44 | $25,932,000.00 | |
| 3/4/2015 | Colleen F Arnold | Director | Sell | 9,801 | $87.65 | $859,057.65 | |
| 3/3/2015 | Richard C Notebaert | Director | Sell | 9,801 | $88.20 | $864,448.20 | |
| 2/20/2015 | Carole S Watkins | Insider | Sell | 33,847 | $87.00 | $2,944,689.00 | |
| 2/10/2015 | Carole S Watkins | Insider | Sell | 50,770 | $85.00 | $4,315,450.00 | |
| 2/10/2015 | George S Barrett | CEO | Sell | 300,000 | $84.87 | $25,461,000.00 | |
| 11/7/2014 | Mark R Blake | EVP | Sell | 24,668 | $79.50 | $1,961,106.00 | |
| 9/5/2014 | Carole S Watkins | Insider | Sell | 40,794 | $75.00 | $3,059,550.00 | |
| 9/4/2014 | Michael C Kaufmann | CEO | Sell | 50,216 | $74.95 | $3,763,689.20 | |
| 8/27/2014 | Jeffrey William Henderson | CFO | Sell | 26,567 | $72.63 | $1,929,561.21 | |
| 8/18/2014 | Jeffrey William Henderson | CFO | Sell | 78,637 | $72.06 | $5,666,582.22 | |
| 8/18/2014 | Mark R Blake | EVP | Sell | 4,782 | $72.15 | $345,021.30 | |
| 8/18/2014 | Michael C Kaufmann | CEO | Sell | 6,833 | $72.06 | $492,385.98 | |
| 8/8/2014 | Craig S Morford | Insider | Sell | 43,359 | $70.03 | $3,036,430.77 | |
| 8/8/2014 | Jeffrey William Henderson | CFO | Sell | 118,093 | $69.72 | $8,233,443.96 | |
| 7/24/2014 | Mark R Blake | EVP | Sell | 23,114 | $73.41 | $1,696,798.74 | |
| 7/24/2014 | Stuart G Laws | CAO | Sell | 21,266 | $72.50 | $1,541,785.00 | |
| 7/14/2014 | Jeffrey William Henderson | CFO | Sell | 23,632 | $70.65 | $1,669,600.80 | |
| 5/19/2014 | Mark Blake | EVP | Sell | 4,703 | $66.50 | $312,749.50 | |
| 5/13/2014 | Mark Blake | EVP | Sell | 2,822 | $66.50 | $187,663.00 | |
| 5/7/2014 | Jeffrey William Henderson | CFO | Sell | 27,031 | $63.83 | $1,725,388.73 | |
| 2/11/2014 | Mark Blake | EVP | Sell | 2,330 | $68.53 | $159,674.90 | |
| 2/11/2014 | Michael Kaufmann | CEO | Sell | 388,995 | $67.46 | $26,241,602.70 | |
| 2/10/2014 | George Barrett | CEO | Sell | 200,000 | $66.64 | $13,328,000.00 | |
| 2/5/2014 | Gregory Kenny | Director | Sell | 18,175 | $65.39 | $1,188,463.25 | |
| 2/4/2014 | Carole Watkins | Insider | Sell | 46,666 | $65.71 | $3,066,422.86 | |
| 2/4/2014 | Falk Stephen | EVP | Sell | 17,926 | $65.56 | $1,175,228.56 | |
| 2/4/2014 | Richard Notebaert | Director | Sell | 10,727 | $65.68 | $704,549.36 | |
| 11/11/2013 | George Barrett | CEO | Sell | 200,000 | $62.71 | $12,542,000.00 | |
| 9/11/2013 | Mark R Blake | EVP | Sell | 14,584 | $51.53 | $751,513.52 | |
| 8/19/2013 | Mark Blake | EVP | Sell | 4,925 | $51.27 | $252,504.75 | |
| 8/16/2013 | Falk Stephen | EVP | Sell | 10,000 | $51.50 | $515,000.00 | |
| 8/15/2013 | Craig Morford | Insider | Sell | 20,000 | $51.33 | $1,026,600.00 | |
| 8/13/2013 | George Barrett | CEO | Sell | 75,000 | $52.09 | $3,906,750.00 | |
| 8/13/2013 | Jeffrey William Henderson | CFO | Sell | 54,590 | $51.99 | $2,838,134.10 | |
| 8/8/2013 | Calvin Darden | Director | Sell | 3,254 | $51.48 | $167,515.92 | |
| 8/5/2013 | Mark Blake | EVP | Sell | 29,166 | $51.53 | $1,502,923.98 | |
| 7/26/2013 | Jeffrey William Henderson | CFO | Sell | 76,781 | $50.99 | $3,915,063.19 | |
| 7/18/2013 | Jeffrey William Henderson | CFO | Sell | 57,623 | $49.99 | $2,880,573.77 | |
| 7/15/2013 | Jeffrey William Henderson | CFO | Sell | 14,660 | $49.99 | $732,853.40 | |
| 7/11/2013 | Jeffrey William Henderson | CFO | Sell | 83,211 | $48.99 | $4,076,506.89 | |
| 6/19/2013 | John F Finn | Director | Sell | 11,070 | $48.51 | $537,005.70 | |
| 5/28/2013 | Jean G Spaulding | Director | Sell | 8,350 | $47.35 | $395,372.50 | |
| 5/22/2013 | Richard C Notebaert | Director | Sell | 3,197 | $48.10 | $153,775.70 | |
| 5/20/2013 | Carole S Watkins | Insider | Sell | 4,612 | $48.00 | $221,376.00 | |
| 5/20/2013 | Jean G Spaulding | Director | Sell | 1,666 | $47.90 | $79,801.40 | |
| 11/1/2012 | Stuart G Laws | CAO | Sell | 2,564 | $41.22 | $105,688.08 | |
| 10/4/2012 | Jeffrey William Henderson | CFO | Sell | 46,226 | $40.00 | $1,849,040.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Cardinal Health (NYSE:CAH)
Latest Headlines for Cardinal Health (NYSE:CAH)
| Source: |
|
| Date | Headline |
|---|
 | Cardinal Health, Inc. (NYSE:CAH) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - July 21 at 8:26 PM |
 | Cardinal Health to explore strategic alternatives, China a big growth driver
seekingalpha.com - July 21 at 6:28 PM |
 | Decreasing the Dosage to Increase Positive Patient Outcomes
finance.yahoo.com - July 21 at 6:28 PM |
| [$$] Cardinal Health Exploring Options for China Unit
finance.yahoo.com - July 21 at 6:28 PM |
| Cardinal puts China unit on block - Seeking Alpha
seekingalpha.com - July 20 at 6:39 PM |
| Cardinal Health Selling China Business Worth Up to $1.5 Billion
finance.yahoo.com - July 20 at 6:39 PM |
| Analysts Anticipate Cardinal Health, Inc. (NYSE:CAH) Will Post Quarterly Sales of $32.81 Billion
www.americanbankingnews.com - July 20 at 9:53 AM |
| Cardinal Health, Inc. (CAH) Expected to Announce Earnings of $1.24 Per Share
www.americanbankingnews.com - July 18 at 10:14 PM |
| Cardinal Health, Inc. (CAH) Short Interest Update
www.americanbankingnews.com - July 18 at 7:00 AM |
| Head to Head Analysis: Cardinal Health (CAH) and MWI Veterinary Supply (MWIV)
www.americanbankingnews.com - July 17 at 11:29 AM |
| Cardinal Health, Inc. (NYSE:CAH) Rating Reiterated by Credit Suisse Group
www.americanbankingnews.com - July 13 at 8:13 AM |
| Cardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2017 on August 2
finance.yahoo.com - July 6 at 6:07 PM |
| Zacks Investment Research Lowers Cardinal Health, Inc. (NYSE:CAH) to Sell
www.americanbankingnews.com - July 4 at 11:04 AM |
| IHS Markit Score Update: Rise in demand for ETFs holding Cardinal Health Inc is a positive for its shares
finance.yahoo.com - July 3 at 4:56 PM |
| IHS Markit Score Update: Drop in demand for ETFs holding Cardinal Health Inc is a negative sign for its shares
finance.yahoo.com - June 30 at 4:58 PM |
| Nashville company settles whistleblower suit for $2.7 million
finance.yahoo.com - June 30 at 4:58 PM |
| Walgreens-Rite Aid Merger Collapses: Is McKesson Victor or Victim?
finance.yahoo.com - June 29 at 6:01 PM |
| Cardinal Health, Inc. (CAH) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - June 26 at 8:13 PM |
| See what the IHS Markit Score report has to say about Cardinal Health Inc.
finance.yahoo.com - June 26 at 4:47 PM |
| Cardinal Health, Inc. (CAH) Expected to Announce Quarterly Sales of $32.84 Billion
www.americanbankingnews.com - June 24 at 8:30 AM |
| Cardinal Health, Inc. (CAH) Expected to Post Earnings of $1.24 Per Share
www.americanbankingnews.com - June 22 at 6:52 PM |
 | How To YieldBoost CAH To 6.3% Using Options - Nasdaq
www.nasdaq.com - June 21 at 5:13 PM |
| ETFs with exposure to Cardinal Health, Inc. : June 15, 2017
finance.yahoo.com - June 15 at 4:17 PM |
| Cardinal Health, Inc. (CAH) Upgraded to Buy by Vetr Inc.
www.americanbankingnews.com - June 14 at 12:22 AM |
| As America’s Opioid Crisis Spirals, Giant Drug Distributor McKesson Is Feeling the Pain
finance.yahoo.com - June 13 at 12:51 PM |
| ValuEngine Lowers Cardinal Health, Inc. (CAH) to Hold
www.americanbankingnews.com - June 11 at 9:34 PM |
| Cardinal Health Inc (CAH) Upgraded to "Buy" by Vetr Inc.
www.americanbankingnews.com - June 11 at 11:28 AM |
| Cardinal Health (CAH) vs. AmerisourceBergen Corp. (ABC) Critical Analysis
www.americanbankingnews.com - June 8 at 7:56 AM |
| John Rogers Buys Cardinal Health, Mattel, Nielsen - Nasdaq
www.nasdaq.com - June 7 at 9:29 PM |
 | 25 Ohio companies make new Fortune 500 list, with Cardinal Health overtaking Kroger - Columbus Business First
www.bizjournals.com - June 7 at 9:29 PM |
| 25 Ohio companies make new Fortune 500 list, with Cardinal Health overtaking Kroger
finance.yahoo.com - June 7 at 12:55 PM |
| Cardinal Health, Inc. breached its 50 day moving average in a Bullish Manner : CAH-US : June 5, 2017
finance.yahoo.com - June 5 at 12:23 PM |
| Reviewing Cardinal Health (CAH) and AmerisourceBergen Corp. (ABC)
www.americanbankingnews.com - June 4 at 4:50 PM |
| Vetr Inc. Downgrades Cardinal Health Inc (CAH) to Hold
www.americanbankingnews.com - June 2 at 12:16 AM |
| Research-Based Insights on Oncology Published by Cardinal Health Specialty Solutions
finance.yahoo.com - June 1 at 4:38 PM |
| Cardinal Health, Inc. -- Moody's assigns Baa2 to Cardinal Health's notes; stable outlook
finance.yahoo.com - June 1 at 4:38 PM |
| Cardinal Health Inc (CAH) Expected to Post Quarterly Sales of $32.84 Billion
www.americanbankingnews.com - May 31 at 1:08 PM |
| Cardinal Health Inc (CAH) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - May 30 at 8:33 PM |
| ETFs with exposure to Cardinal Health, Inc. : May 30, 2017
finance.yahoo.com - May 30 at 4:09 PM |
| Cardinal Health Inc (CAH) Short Interest Update
www.americanbankingnews.com - May 30 at 7:02 AM |
| Brokerages Anticipate Cardinal Health Inc (CAH) Will Announce Earnings of $1.26 Per Share
www.americanbankingnews.com - May 29 at 2:20 PM |
| Electrical Stimulation Therapy and E-Qure - A Potential 20x in 18 Months or Less
finance.yahoo.com - May 25 at 5:27 PM |
| Rebound Reality; Best Tech Story: Jim Cramer's Best Blog
finance.yahoo.com - May 20 at 11:14 AM |
 | Services Stocks Under Scanner -- Rite Aid, Cardinal Health, AmerisourceBergen, and McKesson - PR Newswire (press release)
www.prnewswire.com - May 19 at 9:04 PM |
| Cramer: The Rebound is Real. Now What?
finance.yahoo.com - May 19 at 4:02 PM |
| ETFs with exposure to Cardinal Health, Inc. : May 19, 2017
finance.yahoo.com - May 19 at 4:02 PM |
 | Drug distributor McKesson's upbeat forecast sends shares soaring
www.reuters.com - May 19 at 8:55 AM |
| Cardinal Health, Inc. :CAH-US: Earnings Analysis: Q3, 2017 By the Numbers : May 18, 2017
finance.yahoo.com - May 18 at 11:23 AM |
| Brokers Issue Forecasts for Cardinal Health Inc's FY2017 Earnings (CAH)
www.americanbankingnews.com - May 18 at 10:58 AM |
| A 'smart' parking lot with weather sensors and digital space finders is in the works for Cardinal Health in Dublin
www.bizjournals.com - May 17 at 9:16 PM |
Cardinal Health (CAH) Chart for Sunday, July, 23, 2017
